| Literature DB >> 31637218 |
Alya Limayem1,2, Sarah Wasson1, Mausam Mehta3, Anaya Raj Pokhrel1, Shrushti Patil1, Minh Nguyen4,5, Jing Chen1, Bina Nayak6.
Abstract
Treated wastewater from reclaimed facilities (WWTP) has become a reusable source for a variety of applications, such as agricultural irrigation. However, it is also a potential reservoir of clinically-relevant multidrug resistant (MDR) pathogens, including ESKAPE (Enterococcus faecium and Streptococcus surrogates, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species along with the emerging nosocomial Escherichia strains). This study was performed to decipher the bacterial community structure through Illumina high throughput 16S rRNA gene sequencing, and to determine the resistance profile using the Sensititre antimicrobial susceptibility test (AST) conforming to clinical lab standards (NCCLS). Out of 1747 bacterial strains detected from wastewater influent and effluent, Pseudomonas was the most predominant genus related to ESKAPE in influent, with sequence reads corresponding to 21.356%, followed by Streptococcus (6.445%), Acinetobacter (0.968%), Enterococcus (0.063%), Klebsiella (0.038%), Escherichia (0.028%) and Staphylococcus (0.004%). Despite the different treatment methods used, the effluent still revealed the presence of some Pseudomonas strains (0.066%), and a wide range of gram-positive cocci, including Staphylococcus (0.194%), Streptococcus (0.63%) and Enterococcus (0.037%), in addition to gram-negative Acinetobacter (0.736%), Klebsiella (0.1%), and Escherichia sub-species (0.811%). The AST results indicated that the strains Escherichia along with Klebsiella and Acinetobacter, isolated from the effluent, displayed resistance to 11 antibiotics, while Pseudomonas was resistant to 7 antibiotics, and Streptococcus along with Staphylococcus were resistant to 9 antibiotics. Results herein, proved the existence of some nosocomial MDR pathogens, known for ESKAPE, with potential drug resistance transfer to the non-pathogen microbes, requiring targeted remediation.Entities:
Keywords: bacterial community structure; drug-resistance; pathogens; treated wastewater; wastewater treatment
Year: 2019 PMID: 31637218 PMCID: PMC6787911 DOI: 10.3389/fcimb.2019.00303
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Alpha rarefaction curves calculated for (A) chao1 index demonstrating higher diversity of isolates in untreated influent and (B) observed OTU diversity between untreated influent and treated effluent samples.
Figure 2illumina® 16S Metagenomic report on influent wastewater; classification at the level of: (A) Kingdom (B) Phylum (C) Class.
Figure 3illumina® 16S Metagenomic report on effluent wastewater; classification at the level of: (A) Kingdom (B) Phylum (C) Class.
Classification statistics of each taxonomic level.
| Domain | 195,715 | 99.87% | 148,276 | 98.63% |
| Phylum | 194,415 | 99.21% | 147,661 | 98.22% |
| Class | 192,955 | 98.46% | 145,685 | 96.90% |
| Order | 191,962 | 97.96% | 145,406 | 96.72% |
| Family | 189,908 | 96.91% | 144,880 | 96.37% |
| Genus | 184,240 | 94.02% | 143,449 | 95.45% |
| Species | 119,295 | 60.88% | 126,843 | 84.37% |
Top classifications in untreated influent and treated effluent.
| Domain | Bacteria | 99.78% | 98.62% |
| Phylum | Proteobacteria | 57.53% | 77.18% |
| Class | Gammaproteobacteria | 36.18% | 3.17% |
| Alphaproteobacteria | 1.90% | 69.59% | |
| Order | Pseudomonadales | 27.60% | 2.73% |
| Rhodobacterales | 0.60% | 60.29% | |
| Family | Pseudomonadaceae | 25.39% | 1.80% |
| Rhodobacteraceae | 0.60% | 59.69% | |
| Genus | 38.845% | 1.535% | |
| 21.356% | 0.066% | ||
| Species | Unclassified | 39.12% | 15.63% |
| 38.684% | 0.353% |
Percentage read distribution from phylum level to genera Pseudomonas and Acinetobacter.
| Phylum Proteobacteria | 57.53% | 77.18% |
| Class Gammaproteobacteria | 36.18% | 3.17% |
| Order Pseudomonadales | 27.60% | 2.73% |
| Family | ||
| 1) Pseudomonadaceae | 25.39% | 1.80% |
| Genus | ||
| 1) | 21.356% | 0.066% |
| 2) | 0.968% | 0.736% |
Percentage read distribution from phylum level to genera Streptococcus, Staphylococcus, and Enterococcus.
| Phylum Firmicutes | 16.31% | 4.16% |
| Class Bacilli | 7.83% | 2.01% |
| Order Lactobacillales | 7.57% | 1.90% |
| Family | ||
| 1) Streptococcaceae | 6.85% | 1.70% |
| Genus | ||
| 1) | 6.445% | 0.63% |
Taxonomy list of MDR species identified in both influent and effluent wastewater isolates and potential ESKAPE species.
| Proteobacteria | Gammaproteobacteria | |||
| N/A | N/A | |||
| N/A | ||||
| Alpha proteobacteria | N/A | |||
| N/A | ||||
| Firmicutes | ||||
| N/A | ||||
| Actinobacteria | Actinobacteria | N/A | ||
| Cyanobacteria | Cyanophyceae | N/A | ||
| N/A | ||||
The bold values indicate the relevant ESKAPE species found in the taxonomic reading of the influent and effluent wastewater.
Inhibitory concentration range of antibiotic agents against potential ESKAPE isolates.
| Chloramphenicol | 8–16 | 2–4 | >32 | >32 | >32 |
| Ciprofloxacin | 0.5–1 | 0.5–1 | >4 | >4 | >4 |
| Daptomycin | 8–16 | 8–16 | >16 | >16 | >16 |
| Erythromycin | <0.25 | 1–2 | >8 | >8 | >8 |
| Gentamycin | <128 | <128 | <128 | <128 | <128 |
| Kanamycin | 512–1024 | <128 | <128 | <128 | <128 |
| Streptomycin | <1 | <1 | <1 | <1 | <1 |
| Lincomycin | 4–8 | 4–8 | >8 | >8 | >8 |
| Linezolid | 4–8 | 4–8 | >8 | >8 | >8 |
| Nitrofurantoin | 32–64 | 32–64 | >64 | >64 | >64 |
| Penicillin | 8–16 | 0.5–1 | >16 | >16 | >16 |
| Quinupristin/Dalfopristin | 16–32 | 4–8 | >32 | >32 | >32 |
| Tertacycline | 2–4 | <1 | 4–8 | 4–8 | 4–8 |
| Tigecycline | 0.12–0.25 | 0.12–0.25 | 0.25–0.5 | 0.25–0.5 | 0.25–0.5 |
| Tylosin tartrate | 16–32 | 8–16 | >32 | >32 | >32 |
| Vancomycin | 16–32 | 8–16 | >32 | >32 | >32 |
Percentage read distribution from phylum level to genera Escherichia and Klebsiella.
| Phylum Proteobacteria | 57.53% | 77.18 |
| Class Gammaproteobacteria | 36.18% | 3.17% |
| Order Enterobacteriales | 3.60% | 1.87% |
| Family Enterobacteriaceae | 2.30% | 1.90% |
| Genus | ||
| 1) | 0.028% | 0.811% |